About Max
This author has not written his bio yet.
But we are proud to say that Max contributed 848 entries already.
Entries by Max
Project Navigator
Let's try to finance it!
A new, user friendly way, to get information about current clinical trials available to prostate cancer patients.
Tags
177Lu-PSMA-617 225Ac abiraterone abiraterone acetate ADC ADT ai in healthcare antibody-drug conjugate apalutamide ATM B7-H3 bispecific antibody bone metastases bone metastasis BRCA BRCA2 cancer immunotherapy CAR-T CD3 clinical trial crispr darolutamide docetaxel drug repurposing enzalutamide EZH2 inhibitor HRR immunotherapy mcrpc mHSPC mRNA NEPC neuroendocrine prostate cancer oncolytic virus PARP1 PARP inhibitor Pluvicto prostate cancer protac PSMA radioligand therapy radiopharmaceuticals real-world data STEAP1 T-cell therapy
Latest Posts
- New Phase 2 trial for JNJ-101556143 aka HLD-0915 in mCRPC / mAPMR Prostate Cancer September 22, 2026
- JUR-003 Enters Phase 1 Trial in Metastatic Prostate Cancer September 22, 2026
- Could BAT Make PARP Inhibitors Work Better in Prostate Cancer? September 22, 2026
- ENV105 Phase 2 Trial for mCRPC: Can Prostate Cancer Be Made Sensitive to Hormone Therapy Again? September 22, 2026
